Developer docs
API playgroundTry for free, no card

Search company profiles

Algisys

Full company profile

uuid000azs8

Namestring
Algisys
Legal namestring
AlgiSys, LLC
Websiteurl
algisys.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Algisys BioSciences is a privately held B2B ingredients supplier founded in 2009 and headquartered in Akron/Cleveland, Ohio. The company produces vegan algal EPA omega-3 oils — marketed under the AlgiGOLD brand — and a high-protein vegan biomass branded as Green Protein, both derived from proprietary strains of microalgae grown via heterotrophic fermentation in traditional industrial fermentation equipment. This fermentation-based approach is positioned as the first commercial-scale algal EPA production process and is designed to displace fish oil as the primary source of EPA omega-3 fatty acids.

The company sells its ingredients directly to enterprise manufacturers across seven end markets: dietary supplements, human nutrition, animal and pet nutrition, aquaculture, pharmaceuticals, food & beverage, and cosmetics. Its go-to-market is direct enterprise field sales, with an initial focus on the supplement and aquaculture/animal-feed verticals followed by staged expansion into Pharma, F&B, and cosmetics. Revenue mechanics are framed as one-time ingredient sale transactions; pricing is not publicly disclosed. Algisys protects its position with seven international patents covering strains and processes, a registered AlgiGOLD trademark, and trade-secret-protected strain genetics, and differentiates on sustainability, non-GMO, halal-certified, and high-purity positioning.

Algisys has raised approximately $7 million in Series A funding led by founding Director Michael Finn, supplemented by additional disclosed rounds of roughly $200K (2011), $2.5M (2012), and $6.15M (2013). It is currently pre-commercial-scale, with 1–10 employees, and is in the planning phase for a $75 million fermentation manufacturing facility in Saudi Arabia anchored by MOUs with the Ministry of Investment of Saudi Arabia (MISA) and participation in KAUST's Destination Deep Tech Program. Revenue figures are not disclosed in the source data.

Short descriptiontext

Algisys BioSciences is a privately held B2B ingredients company that produces vegan algal EPA omega-3 oils and high-protein vegan biomass via proprietary heterotrophic fermentation, supplying manufacturers across nutrition, aquaculture, pharmaceutical, food & beverage, and cosmetics markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEdinburgh, United Kingdom
HQ citystring
Edinburgh
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
algal omega-3 oils, algal EPA production, plant-based protein, microalgae fermentation, nutritional ingredients
Industry4 codes
PRIMARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYEUAAAIAI
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHSADAFAJ
Plant-Based & Vegetarian/Vegan Nutrition
NAICS code2 codes
  • Starch and Vegetable Fats and Oils Manufacturing31122
  • Animal Food Manufacturing31111
SIC code1 code
  • Fats & Oils2070
Product category
Algal Omega-3 and Plant Protein Ingredients
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Algal EPA Omega-3 Oil Sales
TypeOne Time License
Description

Sale of algal EPA omega-3 nutritional oils to supplement, pharmaceutical, food & beverage, and cosmetics manufacturers. Initially targeting supplement and human/animal/pet nutrition markets, followed by Pharma, Food & Beverage and cosmetics markets.

algisys.com
2Plant Protein (Green Protein) Sales
TypeOne Time License
Description

Sale of high protein vegan biomass derived from algae after oil extraction and drying. Targets plant-based protein market expected to grow from $18.5 billion to exceed $40 billion by 2025.

algisys.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Algisys manufactures and sells vegan algal EPA Omega-3 nutritional oils and high-protein vegan biomass (Green Protein) produced from proprietary microalgae strains via heterotrophic fermentation. The products target supplement, human/animal/pet nutrition, aquaculture, pharmaceutical, food and beverage, and cosmetics manufacturers as a sustainable, non-GMO, halal-certified replacement for fish oil.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1.8 trillion Peruvian Anchovies Saved over 7-year period
+3 more records
Product overview1 text field

AlgiSys is a BioFoodTech company commercializing patented algal technologies to produce EPA Omega-3 and plant protein products. The core product portfolio consists of AlgiGOLD (algal EPA oil), EPA Omega-3 Nutritional Oils, and Green Protein (vegan biomass). The company uses proprietary strains of microalgae and commercial fermentation technology to produce all-natural, non-GMO, halal, and sustainable omega-3 products that replace fish oil as the primary source, initially targeting the supplement, human, animal, pet nutrition, and aquaculture markets, followed by pharma, food & beverage, and cosmetics markets.

Product and service3 records
1AlgiGOLD
CategoryAlgal Omega-3 EPA Oil
Description

Algal EPA Omega-3 oil product derived from proprietary strains of microalgae using patented fermentation technology. It is a cost-effective, vegan, and sustainable omega-3 supplement with exceptionally high purity standards, isolated from outside pollutants and impurities found in traditionally sourced omega-3, sold to supplement, pharmaceutical, food and beverage, and cosmetics manufacturers.

2EPA Omega-3 Nutritional Oils
CategoryAlgal Omega-3 EPA Oil
Description

All-natural EPA Omega-3 nutritional oils produced from proprietary strains of microalgae using heterotrophic fermentation technology. The first commercial algal EPA production process designed to cost-effectively produce this omega-3 fatty acid, replacing fish oil as the primary source for supplement, pharmaceutical, food and beverage, and cosmetics manufacturers.

3Green Protein (Vegan Biomass)
CategoryPlant-Based Protein
Description

High protein vegan biomass derived from algae strains after oil extraction and drying. Proprietary algae growth and production methods are optimized to attain the highest protein and EPA oil output, offering health benefits including improved digestion, boosted metabolism, and cardiovascular health without added hormones or antibiotics, sold to nutrition, supplement, food and beverage, and animal feed buyers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Strameno Ltd.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership through Memorandum of Understanding between Strameno Ltd. (UK) and AlgiSys Biosciences Inc. (USA). Both companies work at cutting edge of algae technologies. Strameno brings expertise in DHA and niche algae strains combined with AlgiSys expertise in algae commercialization and fermentation technology. Partnership enables creation of new products to supply expanding market for omega-3s, antioxidants, and plant protein, expanding beyond EPA into carotenoids and DHA.

algisys.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AlgiSys selected for KAUST Destination Deep Tech Program - a competitive 3-month program for companies with disruptive technology. AlgiSys is one of only 11 companies selected from a large global pool. Program provides access to world-renowned researchers, unique infrastructure and technology expertise. Technology aligns with Kingdom's 2030 food security and self-sufficiency goals. Dr. Charles Roe will be based at KAUST in Saudi Arabia for 3 months to develop applications and build local partnerships.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Memorandum of Understanding signed with MISA to support food security and health and wellness in the Kingdom. Partnership will facilitate building a manufacturing facility in Saudi Arabia to produce EPA Omega 3s and plant protein from micro-algae. Plant will create local employment and target domestic markets as well as exports to Middle East and Europe. Aligned with Vision 2030 goals.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global food ingredients company that acquired TerraVia (formerly Solazyme) and now produces algae-derived DHA omega-3 (AlgaDHA). Directly comparable fermentation-based algae platform serving nutrition and food customers.

TypeDirect peer
Description

Joint venture between DSM and Evonik producing algal EPA/DHA omega-3 oils for aquaculture and pet food. Most direct head-to-head competitor to Algisys in commercial-scale algal omega-3 with established blue-chip customer base.

TypeDirect peer
Description

Public US company producing high-value microalgae-based products (Spirulina, Hawaiian Astaxanthin) for the supplements and nutrition markets. Comparable in using proprietary algae cultivation to make premium ingredients for human nutrition channels.

TypeBroad incumbent
Description

Global nutrition, health and ingredients giant and parent of the Veramaris JV. Operates broadly across animal nutrition, human nutrition, and personal care with established omega-3 and vitamin franchises — sets the competitive benchmark that Algisys must outperform on cost and purity.

TypeEmerging player
Description

US-based algae technology company developing microalgae-based products for agriculture, nutrition, and aquaculture. Similar early-to-growth stage profile to Algisys, focused on translating proprietary algae cultivation into commercial ingredient products.

TypeRegional player
Description

Among the world's largest aquaculture feed producers, headquartered in Norway with strong European and Latin American presence. A potential anchor customer and competitor for omega-3 supply into farmed fish feed, particularly relevant given Algisys' aquaculture feed focus.

TypeBroad incumbent
Description

Global agricultural processor and nutrition ingredient supplier with significant plant-based protein and specialty ingredient capabilities. Comparable in serving CPG and feed customers seeking plant-based and sustainable ingredient alternatives to animal-derived inputs.

TypeDirect peer
Description

Algae-based ingredient producer supplying natural astaxanthin, beta-glucan, and other microalgae-derived nutrition ingredients. Closely comparable business model — algal biomass fermentation into specialty nutrition ingredients — and notably Charles Bowman (Algisys board member) was a prior C-level executive at BGG.

9Photonz
TypeEmerging player
Description

New Zealand-based company producing EPA and DHA omega-3 from fermentation of microalgae, serving nutraceutical and aquafeed markets. Closely comparable in scale, technology approach (fermentation-derived omega-3), and target customer segments to Algisys.

TypeBroad incumbent
Description

One of the world's largest agribusinesses with deep animal nutrition and aquaculture feed businesses, including omega-3 ingredients. Relevant comparable for go-to-market in animal feed/aquaculture channels and for acquisition as a strategic exit pathway.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Algisys

Algal Omega-3 and Plant Protein Ingredientsalgisys.com

Algisys BioSciences is a privately held B2B ingredients company that produces vegan algal EPA omega-3 oils and high-protein vegan biomass via proprietary heterotrophic fermentation, supplying manufacturers across nutrition, aquaculture, pharmaceutical, food & beverage, and cosmetics markets.

What Algisys does

Algisys BioSciences is a privately held B2B ingredients supplier founded in 2009 and headquartered in Akron/Cleveland, Ohio. The company produces vegan algal EPA omega-3 oils — marketed under the AlgiGOLD brand — and a high-protein vegan biomass branded as Green Protein, both derived from proprietary strains of microalgae grown via heterotrophic fermentation in traditional industrial fermentation equipment. This fermentation-based approach is positioned as the first commercial-scale algal EPA production process and is designed to displace fish oil as the primary source of EPA omega-3 fatty acids.

The company sells its ingredients directly to enterprise manufacturers across seven end markets: dietary supplements, human nutrition, animal and pet nutrition, aquaculture, pharmaceuticals, food & beverage, and cosmetics. Its go-to-market is direct enterprise field sales, with an initial focus on the supplement and aquaculture/animal-feed verticals followed by staged expansion into Pharma, F&B, and cosmetics. Revenue mechanics are framed as one-time ingredient sale transactions; pricing is not publicly disclosed. Algisys protects its position with seven international patents covering strains and processes, a registered AlgiGOLD trademark, and trade-secret-protected strain genetics, and differentiates on sustainability, non-GMO, halal-certified, and high-purity positioning.

Algisys has raised approximately $7 million in Series A funding led by founding Director Michael Finn, supplemented by additional disclosed rounds of roughly $200K (2011), $2.5M (2012), and $6.15M (2013). It is currently pre-commercial-scale, with 1–10 employees, and is in the planning phase for a $75 million fermentation manufacturing facility in Saudi Arabia anchored by MOUs with the Ministry of Investment of Saudi Arabia (MISA) and participation in KAUST's Destination Deep Tech Program. Revenue figures are not disclosed in the source data.

Algisys firmographics

Firmographics
Name
Algisys
Legal name
AlgiSys, LLC
Website
https://algisys.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Short description
Algisys BioSciences is a privately held B2B ingredients company that produces vegan algal EPA omega-3 oils and high-protein vegan biomass via proprietary heterotrophic fermentation, supplying manufacturers across nutrition, aquaculture, pharmaceutical, food & beverage, and cosmetics markets.
Ownership category
akta.pro rank

Algisys industry classification

Industry
Product category
Algal Omega-3 and Plant Protein Ingredients
NAICS
Starch and Vegetable Fats and Oils Manufacturing (31122), Animal Food Manufacturing (31111)
SIC
Fats & Oils (2070)
akta.pro industry
PRIMARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYEUAAAIAI
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYHSADAFAJ
Plant-Based & Vegetarian/Vegan Nutrition

Keywords

  • Algal omega-3 oils
  • Algal EPA production
  • Plant-based protein
  • Microalgae fermentation
  • Nutritional ingredients

Where Algisys is headquartered

Location

Headquarters

HQ city
Edinburgh
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Algisys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Algal EPA Omega-3 Oil Sales: Sale of algal EPA omega-3 nutritional oils to supplement, pharmaceutical, food & beverage, and cosmetics manufacturers. Initially targeting supplement and human/animal/pet nutrition markets, followed by Pharma, Food & Beverage and cosmetics markets.
  2. Plant Protein (Green Protein) Sales: Sale of high protein vegan biomass derived from algae after oil extraction and drying. Targets plant-based protein market expected to grow from $18.5 billion to exceed $40 billion by 2025.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Algisys product offering

Product offering

Core offering

Algisys manufactures and sells vegan algal EPA Omega-3 nutritional oils and high-protein vegan biomass (Green Protein) produced from proprietary microalgae strains via heterotrophic fermentation. The products target supplement, human/animal/pet nutrition, aquaculture, pharmaceutical, food and beverage, and cosmetics manufacturers as a sustainable, non-GMO, halal-certified replacement for fish oil.

Product overview

AlgiSys is a BioFoodTech company commercializing patented algal technologies to produce EPA Omega-3 and plant protein products. The core product portfolio consists of AlgiGOLD (algal EPA oil), EPA Omega-3 Nutritional Oils, and Green Protein (vegan biomass). The company uses proprietary strains of microalgae and commercial fermentation technology to produce all-natural, non-GMO, halal, and sustainable omega-3 products that replace fish oil as the primary source, initially targeting the supplement, human, animal, pet nutrition, and aquaculture markets, followed by pharma, food & beverage, and cosmetics markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • AlgiGOLD Algal EPA Omega-3 oil product derived from proprietary strains of microalgae using patented fermentation technology. It is a cost-effective, vegan, and sustainable omega-3 supplement with exceptionally high purity standards, isolated from outside pollutants and impurities found in traditionally sourced omega-3, sold to supplement, pharmaceutical, food and beverage, and cosmetics manufacturers.
  • EPA Omega-3 Nutritional Oils All-natural EPA Omega-3 nutritional oils produced from proprietary strains of microalgae using heterotrophic fermentation technology. The first commercial algal EPA production process designed to cost-effectively produce this omega-3 fatty acid, replacing fish oil as the primary source for supplement, pharmaceutical, food and beverage, and cosmetics manufacturers.
  • Green Protein (Vegan Biomass) High protein vegan biomass derived from algae strains after oil extraction and drying. Proprietary algae growth and production methods are optimized to attain the highest protein and EPA oil output, offering health benefits including improved digestion, boosted metabolism, and cardiovascular health without added hormones or antibiotics, sold to nutrition, supplement, food and beverage, and animal feed buyers.

Quantifiable outcome

  • 1.8 trillion Peruvian Anchovies Saved over 7-year period
  • +3 more outcomes

Companies that use Algisys

Customer profile

Segments4 records

Ideal customer profiles3 records

Algisys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Algisys partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Strameno Ltd.coreStrategic or Co-development PartnerStrategic partnership through Memorandum of Understanding between Strameno Ltd. (UK) and AlgiSys Biosciences Inc. (USA). Both companies work at cutting edge of algae technologies. Strameno brings expertise in DHA and niche algae strains combined with AlgiSys expertise in algae commercialization and fermentation technology. Partnership enables creation of new products to supply expanding market for omega-3s, antioxidants, and plant protein, expanding beyond EPA into carotenoids and DHA.
  • KAUST (King Abdullah University of Science and Technology)coreStrategic or Co-development PartnerAlgiSys selected for KAUST Destination Deep Tech Program - a competitive 3-month program for companies with disruptive technology. AlgiSys is one of only 11 companies selected from a large global pool. Program provides access to world-renowned researchers, unique infrastructure and technology expertise. Technology aligns with Kingdom's 2030 food security and self-sufficiency goals. Dr. Charles Roe will be based at KAUST in Saudi Arabia for 3 months to develop applications and build local partnerships.
  • Ministry of Investment of Saudi Arabia (MISA)coreStrategic or Co-development PartnerMemorandum of Understanding signed with MISA to support food security and health and wellness in the Kingdom. Partnership will facilitate building a manufacturing facility in Saudi Arabia to produce EPA Omega 3s and plant protein from micro-algae. Plant will create local employment and target domestic markets as well as exports to Middle East and Europe. Aligned with Vision 2030 goals.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Algisys competitors and assessment

Company assessment

Direct peers

  • Corbion: Global food ingredients company that acquired TerraVia (formerly Solazyme) and now produces algae-derived DHA omega-3 (AlgaDHA). Directly comparable fermentation-based algae platform serving nutrition and food customers.
  • Veramaris: Joint venture between DSM and Evonik producing algal EPA/DHA omega-3 oils for aquaculture and pet food. Most direct head-to-head competitor to Algisys in commercial-scale algal omega-3 with established blue-chip customer base.
  • Cyanotech: Public US company producing high-value microalgae-based products (Spirulina, Hawaiian Astaxanthin) for the supplements and nutrition markets. Comparable in using proprietary algae cultivation to make premium ingredients for human nutrition channels.
  • BGG World: Algae-based ingredient producer supplying natural astaxanthin, beta-glucan, and other microalgae-derived nutrition ingredients. Closely comparable business model — algal biomass fermentation into specialty nutrition ingredients — and notably Charles Bowman (Algisys board member) was a prior C-level executive at BGG.

Broad incumbents

  • dsm-firmenich: Global nutrition, health and ingredients giant and parent of the Veramaris JV. Operates broadly across animal nutrition, human nutrition, and personal care with established omega-3 and vitamin franchises — sets the competitive benchmark that Algisys must outperform on cost and purity.
  • ADM: Global agricultural processor and nutrition ingredient supplier with significant plant-based protein and specialty ingredient capabilities. Comparable in serving CPG and feed customers seeking plant-based and sustainable ingredient alternatives to animal-derived inputs.
  • Cargill: One of the world's largest agribusinesses with deep animal nutrition and aquaculture feed businesses, including omega-3 ingredients. Relevant comparable for go-to-market in animal feed/aquaculture channels and for acquisition as a strategic exit pathway.

Emerging players

  • Heliae Development: US-based algae technology company developing microalgae-based products for agriculture, nutrition, and aquaculture. Similar early-to-growth stage profile to Algisys, focused on translating proprietary algae cultivation into commercial ingredient products.
  • Photonz: New Zealand-based company producing EPA and DHA omega-3 from fermentation of microalgae, serving nutraceutical and aquafeed markets. Closely comparable in scale, technology approach (fermentation-derived omega-3), and target customer segments to Algisys.

Regional players

  • BioMar: Among the world's largest aquaculture feed producers, headquartered in Norway with strong European and Latin American presence. A potential anchor customer and competitor for omega-3 supply into farmed fish feed, particularly relevant given Algisys' aquaculture feed focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Algisys social profiles

Digital presence

Algisys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Algisys leadership team

Management profile

Number of profiles

Profiles9 records

Algisys funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Algisys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Algisys

What does Algisys do?

Algisys manufactures and sells vegan algal EPA Omega-3 nutritional oils and high-protein vegan biomass (Green Protein) produced from proprietary microalgae strains via heterotrophic fermentation. The products target supplement, human/animal/pet nutrition, aquaculture, pharmaceutical, food and beverage, and cosmetics manufacturers as a sustainable, non-GMO, halal-certified replacement for fish oil.

Is Algisys a public or private company?

Algisys is a private company. It is classified as venture growth investor backed and is currently operating.

When was Algisys founded?

Algisys was founded in 2009. It employs 1 to 10 people.

Where is Algisys based?

Algisys is headquartered in Edinburgh, United Kingdom, in the Europe region.

How does Algisys make money?

Two revenue lines are on record. Algal EPA Omega-3 Oil Sales are the primary driver. The others are plant Protein (Green Protein) Sales.

Who are Algisys's main competitors?

Direct peers on record are Corbion, Veramaris, Cyanotech and BGG World. Broad incumbents are dsm-firmenich, ADM and Cargill. Emerging players are Heliae Development and Photonz. BioMar is listed as a regional player.

Does Algisys have an API?

No public API is recorded for Algisys.

What industry is Algisys in?

Algisys's product category is Algal Omega-3 and Plant Protein Ingredients. Its primary akta.pro industry code is EUAAAIAJ, Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors), with a secondary code of AFAJAHAF, Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae). Its NAICS code is 31122 and its SIC code is 2070.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals